Ascendis Pharma stock falls on missed Skytrofa revenue forecast
-- Shares of Ascendis Pharma (NASDAQ:ASND) fell 1% after the company provided its full-year guidance for Skytrofa revenue, which fell short of the average analyst...
-- Shares of Ascendis Pharma (NASDAQ:ASND) fell 1% after the company provided its full-year guidance for Skytrofa revenue, which fell short of the average analyst...
By Taosha Wang The past few years haven’t been easy for bond investors, as the "safe haven" asset has struggled in both sunny and cloudy markets. This raises an important...
-- US stock futures fell Monday, as investors fretted that the hot jobs report will prompt the Federal Reserve to hold back on rate cuts this year. Here are some of...
-- Citi analysts assessed the impact of potential new U.S. government AI chip shipment restrictions on Broadcom (NASDAQ:AVGO) Inc., emphasizing that while the...
-- Shares of BMW (BIT:BMW) traded lower on Monday after the company reported adjusted sales guidance for 2024 following a challenging second half of the year. The...
By Victoria Waldersee BERLIN (Reuters) -Germany's top-end carmakers took a battering at home and in China in 2024, sales volume data showed, as wealthier consumers held back on...
-- iRobot (NASDAQ:IRBT) Corporation has announced preliminary revenue for the fourth quarter of about $171 million, falling short of the estimated $188 million,...
By Libby George and Karin Strohecker LONDON(Reuters) - Emerging market countries and companies have issued a flood of bonds topping $55 billion, the most in years, as borrowers...
- Shares in Sage Therapeutics (NASDAQ:SAGE) were more than 36% higher in premarket US trading on Monday, fueled by news that drugmaker Biogen (NASDAQ:BIIB) has...
STOCKHOLM (Reuters) - Sweden's SBB said on Monday it had learned that one of its creditors, U.S. hedge fund Fir Tree Partners, will end remaining legal proceedings against the...